ProKidney Corp. (PROK) Free cash flow
- Free cash flow · 12 months (USD): Value $-159.73M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-159.73M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-141.17M − $18.57M ≈ $-159.73M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-141.17M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.68× | Operating cash flow / net income. Period ending 2026-06-30. $-141.17M ÷ $-84.16M ≈ 1.68× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -141.17M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 18.57M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -159.73M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | (m) | |
| Quarter-end shares | (m) | |
| Net income | -84.16M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-159.73M | (m) | $-141.17M | $18.57M | (m) | (m) | (m) | $-84.16M | (m) | (m) | (m) | 1.68× |
| 2026-03-31 | $-150.06M | (m) | $-132.21M | $17.85M | (m) | (m) | (m) | $-72.29M | (m) | (m) | (m) | 1.83× |
| 2025-12-31 | $-135.31M | (m) | $-120.12M | $15.20M | (m) | (m) | (m) | $-68.99M | (m) | (m) | (m) | 1.74× |
| 2025-09-30 | $-146.73M | (m) | $-111.78M | $34.95M | (m) | (m) | (m) | $-71.03M | (m) | (m) | (m) | 1.57× |
| 2025-06-30 | $-146.58M | (m) | $-114.42M | $32.16M | (m) | (m) | (m) | $-72.47M | (m) | (m) | (m) | 1.58× |
| 2025-03-31 | $-150.98M | (m) | $-121.30M | $29.68M | (m) | (m) | (m) | $-68.43M | (m) | (m) | (m) | 1.77× |
| 2024-12-31 | $-155.86M | (m) | $-126.35M | $29.51M | (m) | (m) | (m) | $-61.19M | (m) | (m) | (m) | 2.07× |
| 2024-09-30 | $-133.14M | (m) | $-127.56M | $5.57M | (m) | (m) | (m) | $-45.61M | (m) | (m) | (m) | 2.80× |
| 2024-06-30 | $-153.21M | (m) | $-122.10M | $31.11M | (m) | (m) | (m) | $-38.68M | (m) | (m) | (m) | 3.16× |
| 2024-03-31 | $-132.89M | (m) | $-98.72M | $34.17M | (m) | (m) | (m) | $-35.30M | (m) | (m) | (m) | 2.80× |
| 2023-12-31 | $-124.27M | (m) | $-90.07M | $34.20M | (m) | (m) | (m) | $-35.47M | (m) | (m) | (m) | 2.54× |
| 2023-09-30 | $-113.38M | (m) | $-80.45M | $32.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-84.82M | (m) | $-79.51M | $5.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $-89.61M | (m) | $-87.62M | $1.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-78.94M | (m) | $-77.09M | $1.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-30.64M | (m) | $-25.18M | $5.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.